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Abstract
Purpose—Metabolic syndrome (MetS), the clustering of several risk factors for cardiovascular 
disease, is highly prevalent in Hispanics/Latinos. We tested whether all components significantly 
loaded on the syndrome in Hispanics/Latinos and whether their contribution differed by sex and 
Hispanic ancestry. We also examined associations of metabolic syndrome with prevalent diabetes 
and coronary heart disease (CHD) in Hispanics/Latinos.
Methods—Data were obtained from a population-based cohort of N = 15,823 participants in the 
HCHS/SOL who self-identified as being of Central American, Cuban, Dominican, Mexican 
American, Puerto Rican, or South American ancestry, aged 18-74 years at screening.
© 2015 Published by Elsevier Inc.
Corresponding author: Maria M. Llabre, Ph.D., Department of Psychology, University of Miami, P O Box 248185, Coral Gables , 
FL 33124, (305) 284-6698 office, (305) 284-2522 fax, mllabre@miami.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
There are no disclosures.
No potential conflicts of interest relevant to this article were reported.
Maria M. Llabre had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of 
the data analysis.
M.L. also researched the literature, interpreted data, organized and wrote the manuscript, except for the methods. W.A. wrote the 
methods and critically reviewed, edited, and contributed to the interpretation of data. D.S-A. reviewed the data analysis, and edited 
and contributed to the interpretation of the data. N.S., L.C.G, G.A.T., and S.F.C. edited and contributed to the interpretation of the 
data. M.L.D., E.C.C., D.A.C., S.C.R., and G.H. were involved in manuscript preparation.
The contents of this article are solely the responsibility of the authors and do not represent the official position of the National 
Institutes of Health, the U.S. Department of Health and Human Services or the federal government.
Preliminary data from this study were presented in a symposium at the 71st Scientific Sessions of the American Diabetes Association, 
San Diego, CA, June 24-28, 2012.
HHS Public Access
Author manuscript
Ann Epidemiol. Author manuscript; available in PMC 2016 July 01.
Published in final edited form as:













Results—A latent variable model of waist circumference, systolic and diastolic blood pressure, 
triglycerides, high-density lipoprotein cholesterol (HDL-C), and fasting glucose fit the data in men 
and women, but the contribution of HDL-C was weak. No difference in the latent model of MetS 
was detected across Hispanic/Latino ancestry groups. MetS was significantly associated with 
diabetes and CHD.
Conclusions—Our results indicate that similar criteria for MetS may be applied across 
Hispanic/Latino ancestry groups; but call into question the role of HDL-C in classifying the MetS 
in Hispanics/Latinos.
Keywords
Metabolic syndrome; Hispanics; Lipids
Introduction
Metabolic syndrome (MetS) refers to the clustering of several risk factors that together 
confer increased risk for cardiovascular disease (CVD). The interrelated factors include 
obesity, hyperglycemia, dyslipidemia, and hypertension. According to a unified definition, 
the presence of three or more of following risk factors results in a diagnosis of MetS: 1) 
waist circumference ≥102 cm in US men and ≥88 cm in US women, 2) systolic/diastolic 
blood pressure ≥130/≥85 mm Hg or use of antihypertensive medication, 3) high-density 
lipoprotein (HDL) cholesterol <40 mg/dL in men and <50 mg/dL in women or use of 
cholesterol medication, 4) triglycerides ≥150 mg/dL or use of lipid lowering medication, and 
5) fasting glucose ≥100 mg/dL or use of medication [1]. Presence of MetS increases the risk 
of CVD [1, 2] and type 2 diabetes (T2D) [3].
Data on the prevalence of MetS among US Hispanics/Latino, based primarily on Mexican 
Americans, indicate increased rates of MetS relative to whites or blacks[4]. Ancestry group 
comparisons from the Multi-Ethnic Study of Atherosclerosis showed that Mexican 
Americans had a higher prevalence of MetS compared to Puerto Ricans and other ancestry 
groups in the US, suggesting that Hispanic/Latinos do not represent a homogeneous group 
with respect to MetS prevalence.
Furthermore, the prevalence of some individual MetS components has been shown to be 
higher for Hispanics/Latinos than non-Hispanic whites, including overweight or obesity and 
dyslipidemia [4]. Hispanics tend to have lower levels of HDL-C cholesterol in comparison 
to Blacks or non-Hispanic Whites [5, 6], and higher triglycerides [5]. Interestingly, HDL-C 
has not been shown to reliably predict myocardial infarction in Hispanics/Latinos, as shown 
in non-Hispanic Whites [7]. Prevalence of hypertension, on the other hand, has been 
reported to be lower in Hispanics/Latinos compared to non-Hispanic Whites [4].
Similar to MetS, diabetes appears to be disproportionately prevalent among Hispanic/
Latinos relative to that of whites and blacks [4]. Paradoxically, prevalence of CVD is lower 
among US Mexican Americans than among whites and blacks [4]. Researchers often refer to 
the unexpected lower CVD rates in a relatively more disadvantaged population as the 
“Hispanic Paradox” [8, 9].
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The HCHS/SOL provides a unique opportunity to examine the MetS in Hispanic/Latinos 
and address fundamental questions, as well as methodological shortcomings in the 
quantification of the MetS. Several methodological criticisms related to MetS have been 
elucidated by Khan et al [10], who point out that there is no empirical rationale for the 
inclusion (or exclusion) of specific indicators, nor for the cutoff values specified in existing 
MetS criteria, which appear arbitrary, given that biological levels of the individual MetS 
components are continuous. It is possible that the risk factors and/or cut-off values do not 
apply in Hispanics/Latinos and their routine application contributes to the Hispanic Paradox. 
To overcome these methodological shortcomings, we specify a latent variable model using 
the current indicators of MetS.
In the most common latent variable measurement model, it is assumed that there is an 
underlying construct or mechanism that explains the covariation among a set of measures. 
Each measure or indictor is linearly related to its latent variable and is expected to contain 
some error or residual variation. The indicators are measured as continuous variables 
without the need to impose cutoffs. The model allows estimation of the contribution of each 
component to the underlying construct, the MetS.
We use this latent variable model approach, consistent with the notion of MetS, to address a 
fundamental question: Do all components of MetS cluster together in Hispanic/Latinos? A 
related question is whether there are differences in the contribution of each component to the 
MetS as a function of sex or Hispanic/Latino ancestry group? We will also assess whether 
MetS, assessed using continuous measures, is associated with prevalent diagnosis of 
diabetes and CHD in Hispanic/Latinos.
Methods
Participants
The purpose, design, and methods of the HCHS/SOL have previously been reported [11, 
12]. Participants were recruited in 4 US communities: the Bronx, NY, Chicago, IL, Miami, 
FL, and San Diego, CA. A two-stage stratified probability sampling plan was used and 
previously described [12]. The study protocol was approved by the institutional review 
board at each site and informed consent was obtained from all participants. Out of the 
16,415 eligible participants between 18 and 74 years old who were assessed at baseline 
between 2008-2011, N = 15,823 identified themselves as being of Central American, Cuban, 
Dominican, Mexican American, Puerto Rican, or South American ancestry. Those of mixed 
background or who identified as “other” were excluded from the current analyses. Two 
participants with missing data on all components of the metabolic syndrome were also 
excluded from analysis; thus the analytic sample size was N = 15823.
Measures
MetS Components—The indicators used in this study are those consistent with current 
definitions of metabolic syndrome. Waist circumference was measured to the nearest 0.1 cm 
at the uppermost lateral border of the right ilium using a measuring tape. After 5 minutes in 
the seated position, systolic (SBP) and diastolic blood pressure (DBP) were measured 3 
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times at 1 minute intervals using an automatic sphygmomanometer (Omron model 
HEM-907 XL, Omron Healthcare Inc., Bannockburn, IL), and the average of the 3 readings 
was used. Measurements of high-density lipoprotein cholesterol (HDL-C), triglycerides 
(TG), and glucose were obtained from fasting blood samples.
Prevalent CHD and Diabetes—Each participant received a standard digital 12-lead 
electrocardiogram (ECG; GEMSIT MAC 1200 portable electrocardiograph) and readings 
were electronically transmitted to a Central ECG Reading Center (The Epidemiological 
Cardiology Research Center of Wake Forest University’s School of Medicine). Guidelines 
to determine wave duration and voltage following the Minnesota Code were used to 
ascertain possible old myocardial infarction (MI). ECG classification criteria for MI by the 
Minnesota Code are detailed elsewhere [13]. Self-reported information on angina, heart 
attack, and coronary procedures (angioplasty, stent, or bypass surgery to the arteries of the 
heart) was collected via standard questionnaire and interview. Prevalent coronary heart 
disease (CHD) was specified as a dichotomous variable that combined information from 
ECG reports of possible old MI as well as self-report of heart attack, coronary procedures, 
and angina.
Diabetes was also specified as a dichotomous variable based on the American Diabetes 
Association definition, taking into account serum glucose levels adjusted for fasting time 
and, if available, glucose level 2-hr after a 75g glucose load, glycosylated hemoglobin A1c
%, scanned/transcribed anti-glycemic medication use, or self-report of diabetes.
Covariates—Standard questionnaires and interviews were used to collect information on 
age, sex, Hispanic/Latino ancestry group, current or previous smoking history, education 
and total household income. Age was examined as a continuous variable. Sex was examined 
as a dichotomous variable. Use of lipid lowering, diabetes, and hypertension medication was 
coded as a dichotomous variable. Hispanic/Latino ancestry group was dummy coded with 
five vectors for Puerto Rican, Cuban, Dominican, Central American, or South American, 
with Mexicans serving as the reference group.
Procedures
Statistical Analysis—We examined a latent variable model for MetS as most consistent 
with the notion of a common underlying pathophysiology using confirmatory factor analysis 
(CFA), where each indicator was assumed to be a manifestation of the syndrome. The 
commonality or common variance among the indicators is represented by a latent variable. 
We tested whether such a model represented good fit to the data. Initially, we assumed 
uncorrelated residuals except for SBP with DBP and HDL-C with triglycerides, but relaxed 
the assumption based on modification indices suggesting added correlations between waist 
with HDL-C and DBP. We then examined the correlations between the latent variable of 
MetS and each of its indicators, also known as factor loadings. The model was first 
examined in men and women separately, as metabolic syndrome criteria vary by sex. We 
then conducted a multiple group analysis to determine the equality of factor loadings 
between sex groups. We systematically compared each unstandardized factor loading using 
a chi-squared difference test appropriate for the maximum likelihood robust method of 
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estimation. This test compares two nested models, one where the loading in question is 
constrained equal between groups to one where the loadings are freely estimated in each 
group. Similarly, the model was examined in each Hispanic/Latino ancestry group and 
compared across ancestry groups using multiple group CFA. Lastly, we examined 
associations between MetS and diagnosis of diabetes and CHD using logistic regression, 
controlling for smoking history, use of medication, and demographic covariates.
Results
Preliminary Analyses
All variable distributions were examined for the presence of outliers, skewness, and kurtosis 
and found to approximate normality, once glucose and triglycerides were log transformed. 
Descriptive statistics were computed on all measures. Table 1 displays the means and 
standard deviations on all measures for participants with complete data.
The initial analysis was conducted on the sample of men (n = 6316) and women (n = 9507) 
separately. Correlations among the six indicators are shown in Table 2 for women and men. 
Several observations are worth noting. The correlations are very similar for both sexes and 
generally modest in magnitude with the exception of correlations between the two measures 
of blood pressure and the two lipid measures. The single indicator most consistently 
associated with the others is waist circumference. Also, of all the indicators, HDL-C has the 
weakest associations with the others.
Confirmatory Factor Analysis Model
The model specified the existence of a continuous underlying construct (latent variable), 
responsible for the clustering or covariation among the indicators that comprise it. We 
selected the CFA model with effect indicators, given that the MetS was assumed to occur on 
a continuum and all indicators were measured concurrently. To determine whether such a 
model fits the data from the HCHS/SOL cohort, we conducted a CFA using the software 
Mplus v7.0 (Muthen & Muthen, 1998-2010) and incorporated the sampling weights, 
stratification, and clustering features of the study design.
Assessment of model fit was based on several common indices [Comparative Fit Index (CFI 
> .95), the Root Mean Squared Error of Approximation (RMSEA < .06), and the 
Standardized Residuals (SRMR < .10)]. We also report the results of the chi-squared test of 
exact fit, but do not use it in model evaluation because such a test is highly dependent on 
sample size and expected to be significant with our large sample, even if departures from 
exact fit are small. The model fit the data for both men [CFI = .97; RMSEA = .06 90%CI (.
051-.069); SRMR = .022; χ2 (5) = 117.67, p < .01)] and women [CFI = .97; RMSEA = .055 
90%CI (0.048-0.063); SRMR = .029; χ2 (5) = 148.56, p < .01)]. This model included 
residual correlations between SBP and DBP, both measures of blood pressure and between 
HDL-C and triglycerides, both indicators of lipids. We also added correlated residuals 
between waist with DBP and HDL-C.
Unstandardized and standardized factor loadings are reported in Table 3 with corresponding 
95% confidence intervals. The loadings were all statistically significant (p < .001), and the 
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unstandardized loadings seemed comparable between men and women, except for the 
loadings associated with systolic blood pressure. The loading for SBP was stronger for 
women than for men χΔ 2 (1) = 192.61, p < .01.
Standardized loadings represent the correlations between the factor and the corresponding 
indicator. In the factor analysis literature, it is common to use a criterion of a correlation of .
30 or greater as indicating an adequate indicator of a factor. As shown in Table 3, the 
standardized loadings associated with HDL-C do not meet this criterion, suggesting that 
HDL-C does not cluster together as strongly with the other risk factors that define MetS in 
Hispanic/Latino men or women. At best, HDL-C appears to be a weak indicator of the 
underlying syndrome in a single factor model.
Hispanic/Latino Ancestry Group Comparisons
Hispanic/Latino ancestry group comparisons were performed for men and women, 
separately, to compare equality of loadings among Mexican (n = 4021 women; n = 2449 
men ) Puerto Rican (n = 1589 women; n = 1139 men), Central American (n = 1049 women; 
n = 683 men), Cuban (n = 1250 women; n = 1098 men), Dominican (n = 963 women; n = 
510 men), or South American (n = 635 women; n = 437 men). The model with loadings 
constrained equal across ancestry groups fit the data for men [CFI = .97; RMSEA = .049 CI 
(.041-.056); SRMR = .08; χ2 (55) = 192.61, p < .01] and women [CFI = .96; RMSEA = .049 
CI (.043-.055); SRMR = .075; χ2 (55) = 262.44, p < .01], indicating the clustering of risk 
factors that form MetS is comparable across Hispanic/Latino subpopulations living in the 
US.
Diabetes and CHD Associations
Lastly, the latent variable of MetS along with age, education, income, current smoker, and 
previous smoker, was used in a logistic regression to predict prevalent CHD and diabetes in 
the sample. The results showed significant associations with both CHD and diabetes. With 
respect to diabetes, adjusting for age, education, income, smoking and use of medication 
(diabetes, lipid, hypertension), the odds ratio (OR) per standard deviation unit in the 
standardized MetS latent variable was 2.39 [95% CI 2.25-2.55] for men and 2.78 [95% CI 
2.60-2.97] for women. With respect to CHD and the same covariates, the OR was 1.18 [95% 
CI 1.08-1.29] for men and 1.22 [95% CI 1.11-1.35] for women. This means that for every 
one standard deviation increase in MetS, the odds of having CHD increase by about 20%, 
while the odds of having diabetes increase over 130% for both men and women. In 
unadjusted models (results not shown) these OR’s were slightly lower than in the adjusted 
models when predicting diabetes but slightly higher when predicting CHD.
Discussion
This study confirmed that current MetS indicators measured as continuous variables 
generally cluster together, as expected, in the largest sample of Hispanics/Latinos studied in 
the US. However, within a single factor, the data indicate that HDL-C does not load strongly 
on the MetS factor. Comparative results indicated similarity between men and women 
except for the contribution of blood pressure to MetS, and across Hispanic/Latino ancestry 
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groups. Systolic blood pressure was a stronger indicator for women relative to men. Lastly, 
results confirmed associations between MetS, measured as a continuous latent variable, and 
prevalent CHD and diabetes diagnoses in Hispanics/Latinos, consistent with prior reports of 
a dose-response association between MetS components and disease (see [14] for review).
It was expected that the latent model analysis would confirm the clustering of current risk 
factors known as MetS in a sample of Hispanic/Latinos. Our results were consistent with the 
work of Shen et al.[15, 16] and others[17] who used similar methodology to support a single 
factor model of MetS in non-Hispanic samples. We extended that work by demonstrating 
comparability in the clustering presentation across Hispanic/Latino ancestry groups. Earlier 
work based on a principal component analysis of the Framingham study data suggested three 
factors [18], and questioned the notion of a single pathophysiological mechanism underlying 
the clustering. More recent work in children, with an expanded set of indicators that 
included multiple measures of glucose metabolism and an optimizing methodology [19], 
suggested two distinct underlying mechanisms: “impaired glucose metabolism” and 
“impaired lipid metabolism”
Given our results indicating a single factor model fit the data may lead one to conclude that 
MetS has a single etiology. However, we caution against this interpretation. In fact, the 
model that fit the data suggested that beyond the single MetS clustering, waist 
circumference was associated with diastolic blood pressure and HDL-C, indicating multiple 
roles of waist circumference, perhaps through different pathophysiological systems, in 
accounting for associations among components of MetS. Also, while HDL-C did not have a 
strong loading on the MetS factor, it correlated with waist circumference. In other analyses 
of the prevalence of MetS components in these data [20], waist circumference was also the 
most prevalent component, underscoring the salience and complexity of this risk factor in 
the context of MetS.
The work of Peeters and colleagues with data from overweight children and adolescents 
[19], would suggest that not a single, but multiple physiological pathways underlie the 
phenotypic expression of the metabolic syndrome. Certainly, the weak loading of HDL-C on 
the MetS factor in our own data coupled with the need to correlate residuals associated with 
the waist circumference indicator, are clues that with a broader set of indicators, a two factor 
solution might have been replicable in our sample. The choice to restrict our analysis to the 
current indicators of the MetS prevented us from being able to conduct a fair test of the two 
factor hypothesis generated by the Peeters et al. study. Further work with a broader set on 
indicators in a Hispanic/Latino population would be both interesting and important.
However, the weak association of HDL-C with the MetS in the current study was 
unexpected as previous CFA studies of the structure of MetS using non-Hispanic cohorts 
reported stronger loadings for HDL-C on the MetS factor than what we found [15,16]. In the 
one study that included Hispanic/Latinos, Shen et al [15] reported similarity between 
Caucasians and Cubans, but the samples were too small (211 Caucasians and 135 Cubans) to 
draw definitive conclusions. Our results suggest that, in the context of a single factor model, 
HDL-C is not a good indicator of MetS in Hispanic/Latinos. HDL-C, however, was also not 
significantly associated with risk of MI among Hispanics in the NOMAS study or the San 
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Antonio Heart Study [7, 21]. Other data from samples of Hispanic/Latinos [22], show that 
Hispanic/Latinos have low HDL-C levels relative to non-Hispanic whites and blacks. As 
noted earlier, the age-adjusted prevalence of MetS is higher in Hispanic/Latinos relative to 
blacks or whites, yet the prevalence of CHD is not. Our findings indicate that using HDL-C 
to classify the MetS in Hispanics/Latinos may increase the rates of false positive 
classifications, thus reducing specificity.
If HDL is to be considered in defining MetS, the commonly assayed HDL-C level may not 
be the most informative parameter, as it may not capture the cardioprotection related to 
HDL. The heterogeneity in HDL particles which vary in concentration, shape, and size has 
led to investigations suggesting that particle-based measures [23] rather than cholesterol 
measures might be more promising in identifying successful therapies [24, 25]. Indices that 
capture cholesterol efflux capacity to reverse cholesterol transport from macrophages have 
shown associations with presence of CHD [26]. While HDL-C levels are correlated with 
HDL efflux capacity, the correlation is not perfect and has not been reported in Hispanic/
Latinos. The HDL-C hypothesis is currently being debated and supplemented by the HDL 
efflux hypothesis[27]. A recent large-scale study of HDL particle subclasses on the basis of 
size (very large, large, medium, small, very small) provides a more nuanced examination of 
the differential associations between HDL particle subclasses and incident CHD [24]. These 
notions need to find their way into the incorporation of other HDL indices in MetS 
definitions.
A recent publication on CHD risk factors in the HCHS/SOL reported heterogeneity among 
the Hispanic/Latino ancestry groups with respect to levels of the individual MetS 
components [28]. This heterogeneity in MetS component levels across ancestry groups does 
not necessarily translate to differential contribution of the specific components to the MetS. 
In fact, we found a striking similarity in the contribution of the MetS components among all 
ancestry groups for both men and women.
We also raise the question of sex differences in the role of blood pressure in the MetS. 
Given that this study was limited to Hispanics/Latinos, it will be important to examine 
whether a similar pattern of sex differences in the contribution of blood pressure to the MetS 
is present in other racial/ethnic groups to determine the generalizability of this finding. 
Furthermore, the target population was limited to four field centers in four communities, 
which are among the ten metropolitan areas with the largest Hispanic/Latino concentration 
in the US. Thus the geographic representation is limited.
Two other important limitations must be considered. Medication use for blood pressure and 
diabetes is taken into account in the MetS classification. In our analyses, participants on 
medication may have negatively biased covariance estimates, as their levels on specific 
indicators would likely regress towards the mean as a result of medication. To assess the 
extent of this potential problem, we repeated the initial models excluding participants on 
medication. As the pattern of results did not change, we believe our conclusions are not 
biased by medication. Nonetheless, how to best account for medication in a latent variable 
model remains a topic for future work. Controlling for medication alone is not sufficient in 
cases where patterns might be moderated by medication. Also, we did not have prospective 
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data at this time on incident CHD and diabetes in the cohort, thus our findings reflect cross-
sectional associations. With the recent funding for the collection of important follow-up 
data, we will be able to report on the extent to which our MetS model can predict future 
diagnoses and/or events.
Despite these limitations, our analysis demonstrates the advantages of a latent variable 
model approach to defining the MetS. First, it is consistent with the concept and allows 
specific examination of the importance of each component. Prior studies based on the 
current criteria have assumed that all components are equally important. Yet we showed that 
this assumption is not necessarily valid in Hispanics/Latinos with respect to HDL-C. Given 
that the components are examined as continuous variables, this latent variable approach does 
not impose an arbitrary cutoff and provides information on degree rather than simply 
presence or absence of risk factors. Further work is needed to examine the sensitivity and 
specificity of various cut-points, particularly for Hispanics/Latinos.
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Our results indicate that similar criteria for MetS may be applied across Hispanic/Latino 
ancestry groups; however the role of HDL-C in the classification is called into question 
by our data. It may be prudent to revisit current guidelines. Also, with respect to blood 
pressure, the gender difference needs further investigation.
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Table 1









Age (years) 41.34 (14.99) 40.55 (14.82) 42.07 (15.11)
Education
 <High School 33.02 32.47 33.53
 High school graduate 28.62 30.67 26.73
 Some college 22.26 20.66 23.73
 College degree 16.10 16.20 16.01
Annual family income ($)
 <20,000 42.44 38.49 46.06
 20,000-50,000 36.77 39.63 34.15
 >50,000 11.44 14.50 8.63
 Not reported 9.36 7.38 11.17
Waist circumference (cm) 97.37 (14.50) 98.27 (14.14) 96.55 (14.77)
SBP (mmHg) 120.00 (17.27) 123.50 (15.06) 116.80 (18.50)
DBP (mmHg) 72.22 (10.89) 73.62 (10.93) 70.94 (10.70)
Triglycerides (mg/dL) 133.90 (118.87) 149.10 (150.69) 120.00 (76.87)
HDL-C (mg/dL) 48.42 (12.76) 44.75 (11.45) 51.77 (12.88)
Fasting glucose (mg/dL) 102.10 (33.35) 104.70 (34.45) 99.68 (32.11)
Cigarette use
 Never 61.46 51.12 70.93
 Previous smoker 17.37 22.14 13.00
 Current smoker 21.17 26.75 16.07
Medication use
 Antihypertensive .131 12.2 13.8
 Lipid lowering .093 8.6 10.0
 Glucose lowering .084 7.9 8.9
CHD 5.95 6.64 5.32
Diabetes 15.72 15.04 16.35
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Table 2
Correlation matrix for women and men
Variable Waist SBP DBP Triglycerides HDL-C Glucose
Waist 1 .164 .287 .292 −.245 .253
SBP .184 1 .709 .279 .042 .244
DBP .344 .704 1 .233 −.041 .157
Triglycerides .307 .160 .287 1 −.403 .287
HDL-C −.255 .032 −.071 −.462 1 −.124
Glucose .229 .158 .127 .257 −.078 1
Note: Correlations for women are above the diagonal and for men are below the diagonal. SBP = systolic blood pressure. DBP = diastolic blood 
pressure. HDL-C= high density lipoprotein cholesterol.
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Table 3
Factor loadings for single latent variable model of metabolic syndrome in women and men
Unstandardized (95%CI) Standardized (95%CI)
Women Men Women Men
Variable
Waist 1 1 .46 (.42−.50) .53 (.47−.59)
SBP 1.32 (1.15−1.48) 0.68 (.57−.78)* .48 (.45−.51) .34 (.29−.39)
DBP 0.55 (.47−.62) 0.65 (.57−.74) .34 (.30−.38) .45 (.40−.50)
Triglycerides 0.20 (.18−.23) 0.21 (.17−.24) .60 (.56−.64) .60 (.55−.65)
HDL-C −0.18 (−.27−−.09) −0.20 (−.30− −.10) −.09 (−.15− −.04) −.13 (−.19− −.07)
Glucose 0.066 (.06−.07) 0.052 (.04−.06) .48 (.44−.52) .41 (.37−.45)
Note: Waist circumference was used to set the metric for the latent variable with a loading of 1. SBP = systolic blood pressure. DBP = diastolic 
blood pressure. HDL-C= high density lipoprotein cholesterol.
*
= p < .05 for sex difference.
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